Elder Pharmaceuticals

2003
 -Elder Pharmaceuticals Limited have forfeited 59750 equity shares of
 the company as the allotment money on those shares were not
 forthcoming from the respective shareholders inspite of final
 reminder for payment of allotment money was sent to them.
 
 -The out come of AGM
                 Decided to increase the authorized capital from from
 the existing Rs.12,00,00,000 (Rupees Twelve crores only) to
 Rs.15,00,00,000 (Rupees Fifteen crores only) by creation of 30,00,000
 (Thiry Lac) new equity shares of Rs.10/- each
                 Appointed the following Directors namely : 1)Mr.Vijay
 N.Paranjpe as Joint Managing Director 2)Mr.Peter Bibby, Mr.Adil
 S.Kajiji,Dr.S.Jayaram & Mr.Saleem Sherwani as Independent Directors.
 
 -Members have approved increase in authorised share capital from
 existing 120 million to Rs 150 million.
 
 2004
 
 -Elder Pharmaceuticals forges alliance with two Spanish companies -
 Ferrer SA and Covex SA - for marketing and manufacturing two products
 in the fast growing cerebro neuropsychiatry (CNS) segment
 
 -Enters into in-licensing agreements with two Japanese pharma
 companies- Tanabe Seiyaku and Fujisawa . Through these two
 agreements, the company procures exclusive marketing rights for two
 anti-hypertensive products in the Indian market
 
 -Ties up with Reliance Life Sciences (RLS) to source aloe vera
 extracts for skin-related products to be developed by the company
 
 - Joins hands with herbal beauty care specialist Shahnaz Husain for
 launch of Fair One, a fairness cream
 
 2005
 
 -Elder Pharmaceuticals has signed a strategic marketing alliance with
 the Swiss pharma major TRB Chemedica to introduce a new range of
 osteoarthritis and pain management drugs in India
 
 2006
 
 -Elder Pharma join hands with Swedish firm Sterisol AB